Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design

Selective CDK2 inhibitors have the potential to provide effective therapeutics for CDK2-dependent cancers and for combating drug resistance due to high cyclin E1 (CCNE1) expression intrinsically or CCNE1 amplification induced by treatment of CDK4/6 inhibitors. Generative models that take advantage o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ACS medicinal chemistry letters 2023-03, Vol.14 (3), p.297-304
Hauptverfasser:	Yu, Yang, Huang, Junhong, He, Hu, Han, Jing, Ye, Geyan, Xu, Tingyang, Sun, Xianqiang, Chen, Xiumei, Ren, Xiaoming, Li, Chunlai, Li, Huijuan, Huang, Wei, Liu, Yangyang, Wang, Xinjuan, Gao, Yongzhi, Cheng, Nianhe, Guo, Na, Chen, Xibo, Feng, Jianxia, Hua, Yuxia, Liu, Chong, Zhu, Guoyun, Xie, Zhi, Yao, Lili, Zhong, Wenge, Chen, Xinde, Liu, Wei, Li, Hailong
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!